Patent Office removes lawyer from case involving Gilead HIV medicine

Patent Office removes lawyer from case involving Gilead HIV medicine

More reads

• U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine. (STAT Plus)
• Kite Pharma's ex-CEO contradicts founder as CAR-T patent trial heats up, with conflicting valuations. (Endpoints)
• BMJ should retract flawed research paper on chronic fatigue syndrome. (STAT)